Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECC4703 and ECC0509 in Adults With Presumed MASH
NCT07288138Phase 2Recruiting
- Sponsor
- Eccogene
- Start
- Dec 2025
- Primary completion
- Sep 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ECC4703, ECC0509 in metabolic dysfunction-associated steatohepatitis (MASH), sponsored by Eccogene. Started Dec 2025; status: recruiting.
02
Drugs
ECC4703ECC0509
03
Conditions
metabolic dysfunction-associated steatohepatitis (MASH)
Beyond the preview
Go deeper on NCT07288138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07288138.